Search Results
You are looking at 1 - 4 of 4 items for
- Author or Editor: William H. Brown x
- Refine by Access: All Content x
Objective
To compare prevalence estimates of brucellosis (BR) in adult beef cattle that originated from different states and regions of Mexico and that were shipped direct-to-slaughter into Texas during 1995.
Design
Epidemiologic survey.
Animals
About 65,000 adult beef cattle.
Procedure
Blood samples were collected during postmortem examinations and were tested for serum antibodies to Brucella abortus, using the particle concentration fluorescence immunoassay and automated complement-fixation test. Prevalence estimates and 95% confidence intervals of BR were calculated by state of origin in Mexico. The difference among prevalence estimates of BR in cattle from different states and regions was tested for significance (P< 0.05), using the proportion test.
Results
On the basis of serologic test results, the overall prevalence estimate of BR was 0.32%. The prevalence estimate of BR in cattle from the state of Chihuahua (0.10%) was significantly different than that in cattle from the states of Nuevo Leon (0.23%), Zacatecas (0.34%), Durango (0.47%), Chiapas (1.81%), Tamaulipas (2.71%), Aguascalientes (7.89%), and Campeche (12.24%). In addition, prevalence estimates of BR in cattle were significantly different among the northern (0.22%), south-central (3.18%), and south coastal (9.42%) regions of Mexico.
Clinical Implications
Results of this study indicate that the number of cattle exposed to B abortus may be significantly different among states and regions of Mexico. Current import sanitary requirements should continue to mitigate potential risk of transmission of BR from sexually intact cattle of Mexican origin to Texas cattle. (J Am Vet Med Assoc 1998; 212:705-707)
Abstract
Objective—To determine the efficacy of long-term enalapril administration in delaying the onset of congestive heart failure (CHF).
Design—Placebo-controlled, double-blind, multicenter, randomized trial.
Animals—124 dogs with compensated mitral valve regurgitation (MR).
Procedures—Dogs randomly assigned to receive enalapril or placebo were monitored for the primary endpoint of onset of CHF for ≤ 58 months. Secondary endpoints included time from study entry to the combined endpoint of CHF-all-cause death; number of dogs free of CHF at 500, 1,000, and 1,500 days; and mean number of CHF-free days.
Results—Kaplan-Meier estimates of the effect of enalapril on the primary endpoint did not reveal a significant treatment benefit. Chronic enalapril administration did have a significant benefit on the combined endpoint of CHF-all-cause death (benefit was 317 days [10.6 months]). Dogs receiving enalapril remained free of CHF for a significantly longer time than those receiving placebo and were significantly more likely to be free of CHF at day 500 and at study end.
Conclusions and Clinical Relevance—Chronic enalapril treatment of dogs with naturally occurring, moderate to severe MR significantly delayed onset of CHF, compared with placebo, on the basis of number of CHF-free days, number of dogs free of CHF at days 500 and study end, and increased time to a combined secondary endpoint of CHF-all-cause death. Improvement in the primary endpoint, CHF-free survival, was not significant. Results suggest that enalapril modestly delays the onset of CHF in dogs with moderate to severe MR.
Objective
To evaluate differences in prevalence of tuberculosis (TB) in adult beef cattle that originated from different states in Mexico and were shipped direct-to-slaughter into Texas in 1995.
Design
Epidemiologic survey.
Animals
Approximately 65,000 adult beef cattle.
Procedures
Postmortem examinations of carcasses for detection of Mycobacterium bovis infection were conducted at slaughter plants in Texas. Specimens were collected from cattle with granulomatous lesions, stored in neutral-buffered 10% formalin or saturated sodium borate solution, and processed for histologic and bacteriologic diagnosis. Prevalence and 95% confidence intervals were estimated by state of origin. Difference between prevalences for different states was tested for significance (P< 0.05), using the proportion test.
Results
Overall prevalence of TB at slaughter in adult beef cattle that originated from Mexico was approximately 0.5/1,000 (34/65,233). Prevalence of TB in cattle that originated from Chihuahua (0.07) was significantly lower than that in cattle from Coahuila (0.80), Nuevo Leon (1.27), and Tamaulipas (1.81).
Clinical Implications
Prevalence of M bovis infection in adult beef cattle may be significantly different between states in the northern border region of Mexico. On the basis of disease prevalence and numbers of exported cattle and provided safeguards such as TB testing are continued, cattle from Chihuahua may pose a lower risk of TB transmission to Texas cattle than do cattle from Coahuila, Nuevo Leon, and Tamaulipas. To allow interstate/international movement of cattle from northern border states of Mexico, TB testing requirements should be continued. In the context of international trade, southern border states of the United States should continue collaborating with northern border states of Mexico to control and eradicate this disease. (J Am Vet Med Assoc 1998; 212:557-559)
Abstract
Objective—To evaluate a portable real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay designed to detect all 7 viral serotypes of footand- mouth disease virus (FMDV).
Design—Laboratory and animal studies.
Study Population—Viruses grown in tissue culture and animals experimentally infected with FMDV.
Procedure—1 steer, pig, and sheep were infected with serotype O FMDV. Twenty-four hours later, animals were placed in separate rooms that contained 4 FMDV-free, healthy animals of the same species. Oral and nasal swab specimens, oropharyngeal specimens obtained with a probang, and blood samples were obtained at frequent intervals, and animals were observed for fever and clinical signs of foot-and-mouth disease (FMD). Samples from animals and tissue cultures were assayed for infectious virus and viral RNA.
Results—The assay detected viral RNA representing all 7 FMDV serotypes grown in tissue culture but did not amplify a panel of selected viruses that included those that cause vesicular diseases similar to FMD; thus, the assay had a specificity of 100%, depending on the panel selected. The assay also met or exceeded sensitivity of viral culture on samples from experimentally infected animals. In many instances, the assay detected viral RNA in the mouth and nose 24 to 96 hours before the onset of clinical disease.
Conclusions and Clinical Relevance—The assay reagents are produced in a vitrified form, which permits storage and transportation at ambient temperatures. The test can be performed in 2 hours or less on a portable instrument, thus providing a rapid, portable, sensitive, and specific method for detection of FMDV. (J Am Vet Med Assoc 2002;220:1636–1642)